chr14-105249039-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001387567.1(BTBD6):​c.328C>G​(p.Gln110Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000201 in 149,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

BTBD6
NM_001387567.1 missense

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.322
Variant links:
Genes affected
BTBD6 (HGNC:19897): (BTB domain containing 6) Predicted to be involved in neurogenesis. Predicted to be located in cytoplasm. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
BRF1 (HGNC:11551): (BRF1 RNA polymerase III transcription initiation factor subunit) This gene encodes one of the three subunits of the RNA polymerase III transcription factor complex. This complex plays a central role in transcription initiation by RNA polymerase III on genes encoding tRNA, 5S rRNA, and other small structural RNAs. The gene product belongs to the TF2B family. Several alternatively spliced variants encoding different isoforms, that function at different promoters transcribed by RNA polymerase III, have been identified. [provided by RefSeq, Jun 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.061746508).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BTBD6NM_001387567.1 linkc.328C>G p.Gln110Glu missense_variant Exon 1 of 4 ENST00000392554.8 NP_001374496.1
BRF1NM_001519.4 linkc.544+3468G>C intron_variant Intron 5 of 17 ENST00000547530.7 NP_001510.2 Q92994-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BTBD6ENST00000392554.8 linkc.328C>G p.Gln110Glu missense_variant Exon 1 of 4 1 NM_001387567.1 ENSP00000376337.4 Q96KE9-3A0A8C8KHP4
BRF1ENST00000547530.7 linkc.544+3468G>C intron_variant Intron 5 of 17 1 NM_001519.4 ENSP00000448387.2 Q92994-1

Frequencies

GnomAD3 genomes
AF:
0.0000201
AC:
3
AN:
149546
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000487
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000667
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1110724
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
535324
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000201
AC:
3
AN:
149546
Hom.:
0
Cov.:
33
AF XY:
0.0000137
AC XY:
1
AN XY:
72920
show subpopulations
Gnomad4 AFR
AF:
0.0000487
Gnomad4 AMR
AF:
0.0000667
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000189

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 06, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.169C>G (p.Q57E) alteration is located in exon 2 (coding exon 1) of the BTBD6 gene. This alteration results from a C to G substitution at nucleotide position 169, causing the glutamine (Q) at amino acid position 57 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
0.018
DANN
Benign
0.45
DEOGEN2
Benign
0.020
T;.;T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0070
N
LIST_S2
Benign
0.25
T;T;.
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.062
T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.34
N;.;N
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.010
N;N;N
REVEL
Benign
0.11
Sift
Benign
0.36
T;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
B;.;B
Vest4
0.078
MutPred
0.17
Loss of MoRF binding (P = 0.0722);Loss of MoRF binding (P = 0.0722);Loss of MoRF binding (P = 0.0722);
MVP
0.35
MPC
0.43
ClinPred
0.13
T
GERP RS
-5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.032
gMVP
0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1027752644; hg19: chr14-105715376; API